speb/financial-data huggingface dataset:
Financial ratios for 9223.T — annual report dated 2024-03-31
Total revenue: 24997187.004754357
Gross profit: 7506781.563655573
Operating income: 2308637.0839936608
Net income: 1387539.6196513472
Capital expenditures: 20412183.042789225
Operating cash flow: 11426749.867934495
Depreciation & amortization: 9949128.367670365
Net tangible assets: 19592320.390913893
Owner earnings: -9075515.055467512
Return on net tangible assets (%): -46.32179790034651
Capex to operating income (%): 884.1659516045993
Buffett classification: The Gruesome
Stock price: 3.9281563655573164
P/E ratio: 35.21184319042112
Shares outstanding: 12437852
Book value: 19990788.43106181
P/B ratio: 2.44401703695409
Market cap (USD): 48857827.5076598
Debt to equity: 1.929696885616559
Current ratio: 0.6552521454540936
Quick ratio: 0.6367189456051224
Effective tax rate (%): 35.209361124815
Interest coverage ratio: 18.335431088735053
COGS to revenue (%): 69.9694947186345
Free cash flow (dilution-adjusted): -9148111.46328579
Buyback yield (%): 0
Retained earnings: 15351703.645007923
Inventory turnover: 52.23837885810079
Receivables turnover: 6.071460762819104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.2570870757486965
FCF margin (%): -36.59656369153001
Revenue growth (%): 6.005060449845684
Rule of 40 score: -30.591503241684325
Financial ratios for 9223.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 20784815.80053229
Buffett classification: The Gruesome
Stock price: 3.985222019890741
Shares outstanding: 12437852
Book value: 21137365.177195676
P/B ratio: 2.3450227242144046
Market cap (USD): 49567601.67054209
Debt to equity: 2.548098355430249
Current ratio: 0.6932374384673636
Quick ratio: 0.6489829854341864
Buyback yield (%): 0
Retained earnings: 16018532.007283933
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9223.T — annual report dated 2025-03-31
Total revenue: 28514469.99064296
Gross profit: 6735356.235797353
Operating income: 325959.0963774896
Net income: -165519.31559951877
Capital expenditures: 19879655.126320012
Operating cash flow: 9904457.960165752
Depreciation & amortization: 12148676.647507017
Net tangible assets: 19614336.318673972
Owner earnings: -7896497.794412512
Return on net tangible assets (%): -40.258806956902205
Capex to operating income (%): 6098.818946073407
Buffett classification: The Gruesome
Stock price: 3.776099451944927
Shares outstanding: 12437852
Book value: 19910914.31626787
P/B ratio: 2.3588352284856597
Market cap (USD): 46966566.12057211
Debt to equity: 3.2224059111045036
Current ratio: 0.9040407890131202
Quick ratio: 0.8730417782054224
Effective tax rate (%): 134.94623655913978
Interest coverage ratio: 1.0436327063405448
COGS to revenue (%): 76.37916384906484
Free cash flow (dilution-adjusted): -10101383.504879026
Buyback yield (%): 0
Retained earnings: 15206663.547654057
Inventory turnover: 22.698776801014223
Receivables turnover: 6.662910679341757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5856226692770125
FCF margin (%): -35.42546471385861
Revenue growth (%): 14.070715177750328
Rule of 40 score: -21.35474953610828
Financial ratios for 9223.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 19614336.318673972
Buffett classification: The Gruesome
Stock price: 3.776099451944927
Shares outstanding: 12437852
Book value: 19910914.31626787
P/B ratio: 2.3588352284856597
Market cap (USD): 46966566.12057211
Debt to equity: 3.2224059111045036
Current ratio: 0.9040407890131202
Quick ratio: 0.8730417782054224
Buyback yield (%): 0
Retained earnings: 15206663.547654057
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9223.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.192084140603376
Shares outstanding: 12437852
Market cap (USD): 52140522.11237199
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9223.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 10138270.524899058
Buffett classification: The Gruesome
Stock price: 4.103566621803499
Shares outstanding: 12437852
Book value: 18957570.659488566
P/B ratio: 2.6923045801011316
Market cap (USD): 51039554.31413189
Debt to equity: 3.1914049756930445
Current ratio: 0.6811541310018238
Quick ratio: 0.6315649169496624
Buyback yield (%): 0
Retained earnings: 14153371.467025572
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIN.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 54.48863636363637
Shares outstanding: 11292288
Market cap (USD): 615301374.5454546
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIN.DE — annual report dated 2022-12-31
Total revenue: 511025531.9148936
Gross profit: 144873404.25531915
Operating income: 32251063.829787236
Net income: 26238297.872340426
Capital expenditures: 7813829.787234043
Operating cash flow: 33706382.97872341
Depreciation & amortization: 29106382.978723407
Net tangible assets: -160367021.27659574
Owner earnings: 47530851.06382979
Return on net tangible assets (%): -29.63879398985041
Capex to operating income (%): 24.22813036020583
Buffett classification: The Great
Stock price: 26.308510638297875
P/E ratio: 11.32250576710996
Shares outstanding: 11292288
Book value: 192357446.80851066
P/B ratio: 1.5444334696044597
Market cap (USD): 297083278.9787234
Debt to equity: 1.069059154057163
Current ratio: 1.2845612582781456
Quick ratio: 1.2652379200392443
Effective tax rate (%): 28.468474741496358
Interest coverage ratio: 4.979632063074901
COGS to revenue (%): 71.65045673697446
SG&A to revenue (%): 1.6354264682615682
Free cash flow (dilution-adjusted): 25892553.191489365
Buyback yield (%): 0
Retained earnings: 47051063.82978724
Inventory turnover: 136.52637842126143
Receivables turnover: 7.1471038966835785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.918898939741034
FCF margin (%): 5.066782689793574
Rule of 40 score: 5.066782689793574
Financial ratios for AEIN.DE — annual report dated 2023-12-31
Total revenue: 467280000
Gross profit: 149333333.33333334
Operating income: 32814444.444444444
Net income: 18534444.444444444
Capital expenditures: 15970000
Operating cash flow: 35104444.44444444
Depreciation & amortization: 28886666.666666664
Net tangible assets: -168740000
Owner earnings: 31451111.111111104
Return on net tangible assets (%): -18.638799994732196
Capex to operating income (%): 48.667592185013376
Buffett classification: The Good
Stock price: 21.222222222222225
P/E ratio: 12.929842383550149
Shares outstanding: 11292288
Book value: 210216666.6666667
P/B ratio: 1.140002118449219
Market cap (USD): 239647445.33333337
Debt to equity: 1.0564602658632627
Current ratio: 1.2418521166621979
Quick ratio: 1.232549825721691
Effective tax rate (%): 27.013214236382893
Interest coverage ratio: 2.75237651444548
COGS to revenue (%): 68.04200194030703
SG&A to revenue (%): 2.293414369685556
Free cash flow (dilution-adjusted): 18913333.333333332
Buyback yield (%): 0
Retained earnings: 56631111.11111111
Inventory turnover: 229.10488390712572
Receivables turnover: 6.142763244380176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.563100530618098
FCF margin (%): 4.047537522113793
Revenue growth (%): -8.560341740846527
Rule of 40 score: -4.512804218732733
Financial ratios for AEIN.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.333333333333332
Shares outstanding: 11292288
Market cap (USD): 184440704
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIN.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.3125
Shares outstanding: 11292288
Market cap (USD): 161620872
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIN.DE — annual report dated 2024-12-31
Total revenue: 337244791.6666667
Gross profit: 115758333.33333334
Operating income: 17981250
Net income: 13635416.666666668
Capital expenditures: 11697916.666666668
Operating cash flow: 39369791.66666667
Depreciation & amortization: 29450000
Net tangible assets: -144045833.33333334
Owner earnings: 31387500.000000004
Return on net tangible assets (%): -21.7899395447051
Capex to operating income (%): 65.05619279341907
Buffett classification: The Good
Stock price: 14.3125
P/E ratio: 11.85302040641711
Shares outstanding: 11292288
Book value: 202277083.3333333
P/B ratio: 0.7990073286436715
Market cap (USD): 161620872
Debt to equity: 0.9564489716045442
Current ratio: 1.585836118474127
Quick ratio: 1.5699781030310014
Effective tax rate (%): 10.99539355097136
Interest coverage ratio: 1.4226141420801055
COGS to revenue (%): 65.67527914626801
SG&A to revenue (%): 2.9420395051813872
Free cash flow (dilution-adjusted): 26843750
Buyback yield (%): 0
Retained earnings: 54162500
Inventory turnover: 154.52543604651163
Receivables turnover: 5.257896873731222
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.496401472231556
FCF margin (%): 7.959722629766334
Revenue growth (%): -27.82811340809222
Rule of 40 score: -19.86839077832589
Financial ratios for AEIN.DE — quarterly report dated 2025-03-31
Total revenue: 103951086.95652173
Gross profit: 19050000
Operating income: 2467391.304347826
Net income: -19565.217391304348
Capital expenditures: 2688043.4782608696
Operating cash flow: 12388043.47826087
Depreciation & amortization: 7323913.043478261
Net tangible assets: -152513043.47826087
Owner earnings: 4616304.347826086
Capex to operating income (%): 108.94273127753304
Buffett classification: The Gruesome
Stock price: 18.608695652173914
Shares outstanding: 11292288
Book value: 208740217.39130437
P/B ratio: 1.0066807117230174
Market cap (USD): 210134750.60869566
Debt to equity: 0.16537614363599434
Current ratio: 1.5892739635885065
Quick ratio: 1.5660110648046601
Interest coverage ratio: 0.8438661710037175
COGS to revenue (%): 81.67407329952422
Free cash flow (dilution-adjusted): 9433695.652173912
Buyback yield (%): 0
Retained earnings: 54217391.30434782
Inventory turnover: 40.91618648507072
Receivables turnover: 1.5672216577627742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6051864747487943
FCF margin (%): 9.075129398232864
Rule of 40 score: 9.075129398232864
Financial ratios for AEIN.DE — quarterly report dated 2025-06-30
Total revenue: 107349411.76470588
Gross profit: 18387058.82352941
Operating income: 320000
Net income: -2781176.470588235
Capital expenditures: 2802352.941176471
Operating cash flow: -5195294.117647059
Depreciation & amortization: 7928235.294117647
Net tangible assets: -174998823.52941176
Owner earnings: 2344705.882352941
Capex to operating income (%): 875.7352941176471
Buffett classification: The Gruesome
Stock price: 21.83529411764706
Shares outstanding: 11292288
Book value: 215805882.35294122
P/B ratio: 1.1425565746994846
Market cap (USD): 246570429.7411765
Debt to equity: 0.1725297789407692
Current ratio: 1.6114058871605932
Quick ratio: 1.5848630696781392
Interest coverage ratio: 0.10183451890677649
COGS to revenue (%): 82.87176564708977
Free cash flow (dilution-adjusted): -8167058.823529412
Buyback yield (%): 0
Retained earnings: 48361176.47058824
Inventory turnover: 36.95894428152492
Receivables turnover: 1.4549005851682955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.07308802270027999
FCF margin (%): -7.607921356318564
Revenue growth (%): 3.2691575506137034
Rule of 40 score: -4.338763805704861
Financial ratios for AEIN.DE — quarterly report dated 2025-09-30
Total revenue: 99664705.88235295
Gross profit: 22947058.82352941
Operating income: 5820000
Net income: 3329411.7647058824
Capital expenditures: 3298823.529411765
Operating cash flow: 19374117.647058822
Depreciation & amortization: 8321176.470588235
Net tangible assets: -126422352.94117647
Owner earnings: 8351764.705882354
Return on net tangible assets (%): -6.60624051964005
Capex to operating income (%): 56.68081665655953
Buffett classification: The Good
Stock price: 20.400000000000002
P/E ratio: 435.73995454114436
Shares outstanding: 11292288
Book value: 219830588.2352941
P/B ratio: 1.0479100158410757
Market cap (USD): 230362675.20000002
Debt to equity: 0.13630282142398426
Current ratio: 2.1752840692442614
Quick ratio: 2.166895447266072
Effective tax rate (%): 14.12250079339892
Interest coverage ratio: 2.627190653212958
COGS to revenue (%): 76.97574219441657
Free cash flow (dilution-adjusted): 16054117.647058824
Buyback yield (%): 0
Retained earnings: 50227058.823529415
Inventory turnover: 98.8030303030303
Receivables turnover: 1.44816916817669
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.33213772155171
FCF margin (%): 16.10812725019182
Revenue growth (%): -7.158591515337482
Rule of 40 score: 8.949535734854338
Financial ratios for AEIN.DE — quarterly report dated 2025-12-31
Total revenue: 92395294.11764707
Gross profit: 77889411.76470588
Operating income: 14178823.529411765
Net income: 28785882.352941178
Capital expenditures: 3591764.7058823532
Operating cash flow: 19187058.82352941
Depreciation & amortization: 6982352.94117647
Net tangible assets: -98184705.88235295
Owner earnings: 32176470.588235293
Return on net tangible assets (%): -32.77136729094024
Capex to operating income (%): 25.331895121141724
Buffett classification: The Good
Stock price: 22.941176470588236
P/E ratio: 8.837193485598922
Shares outstanding: 11292288
Book value: 241222352.94117644
P/B ratio: 1.0739401577260914
Market cap (USD): 259058371.7647059
Debt to equity: 0.508366700969084
Current ratio: 1.4891220420584095
Quick ratio: 1.4851364854430669
Effective tax rate (%): 24.525702172761
Interest coverage ratio: 7.0644783118405625
COGS to revenue (%): 15.699806458184778
Free cash flow (dilution-adjusted): 15595294.11764706
Buyback yield (%): 0
Retained earnings: 78002352.94117647
Inventory turnover: 35.128205128205124
Receivables turnover: 1.3412118314092494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8256673967558648
FCF margin (%): 16.87888356931853
Revenue growth (%): -7.293867673965648
Rule of 40 score: 9.58501589535288
Financial ratios for AEIN.DE — annual report dated 2025-12-31
Total revenue: 385442352.9411765
Gross profit: 134824705.88235295
Operating income: 21861176.470588237
Net income: 27163529.411764707
Capital expenditures: 12650588.235294119
Operating cash flow: 46774117.64705882
Depreciation & amortization: 31158823.529411767
Net tangible assets: -98184705.88235295
Owner earnings: 45671764.705882356
Return on net tangible assets (%): -46.516170003714485
Capex to operating income (%): 57.86782908190722
Buffett classification: The Good
Stock price: 22.941176470588236
P/E ratio: 9.536992334011867
Shares outstanding: 11292288
Book value: 241222352.94117644
P/B ratio: 1.0739401577260914
Market cap (USD): 259058371.7647059
Debt to equity: 0.508366700969084
Current ratio: 1.4891220420584095
Quick ratio: 1.4851364854430669
Effective tax rate (%): 28.49144305937038
Interest coverage ratio: 2.142264237952502
COGS to revenue (%): 65.02078589611325
SG&A to revenue (%): 3.24485846666626
Free cash flow (dilution-adjusted): 33692941.17647059
Buyback yield (%): 0.16167148992666727
Retained earnings: 78002352.94117647
Inventory turnover: 606.9088319088319
Receivables turnover: 5.595088462326662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.898485858489669
FCF margin (%): 8.741369732560909
Revenue growth (%): 14.291565790035488
Rule of 40 score: 23.032935522596397
Financial ratios for AEP.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.14772727272728
Shares outstanding: 544105032
Market cap (USD): 46329306872.45455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEP.DE — annual report dated 2022-12-31
Total revenue: 19639500000
Gross profit: 11292200000
Operating income: 3778500000
Net income: 2307200000
Capital expenditures: 100700000
Operating cash flow: 5288000000
Depreciation & amortization: 3285700000
Net tangible assets: 23840900000
Owner earnings: 5492200000
Return on net tangible assets (%): 23.03688199690448
Capex to operating income (%): 2.6650787349477305
Buffett classification: The Great
Stock price: 90.54255319148936
P/E ratio: 21.35257402982707
Shares outstanding: 544105032
Book value: 24122400000
P/B ratio: 2.0422784964023903
Market cap (USD): 49264658801.61702
Debt to equity: 1.723680065001824
Current ratio: 0.5107301960606951
Quick ratio: 0.40895351379058215
Effective tax rate (%): 0.22310361923648983
Interest coverage ratio: 2.706468018050283
COGS to revenue (%): 42.50260953690267
Free cash flow (dilution-adjusted): -1484400000
Buyback yield (%): 0
Retained earnings: 12345600000
Inventory turnover: 6.182269293438009
Receivables turnover: 7.096733395967334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.715050476059748
FCF margin (%): -7.558237225998625
Rule of 40 score: -7.558237225998625
Financial ratios for AEP.DE — annual report dated 2023-12-31
Total revenue: 18982000000
Gross profit: 11128000000
Operating income: 3735000000
Net income: 2213000000
Capital expenditures: 128000000
Operating cash flow: 5012000000
Depreciation & amortization: 3187000000
Net tangible assets: 25194200000
Owner earnings: 5272000000
Return on net tangible assets (%): 20.925451095887148
Capex to operating income (%): 3.427041499330656
Buffett classification: The Great
Stock price: 94.56666666666666
P/E ratio: 23.250880792046996
Shares outstanding: 544105032
Book value: 25285900000
P/B ratio: 2.03489688691326
Market cap (USD): 51454199192.799995
Debt to equity: 1.7246172768222607
Current ratio: 0.5250612935529542
Quick ratio: 0.36280603612003176
Effective tax rate (%): 2.489814395654142
Interest coverage ratio: 2.066961815163254
COGS to revenue (%): 41.37604045938257
Free cash flow (dilution-adjusted): -2494000000
Buyback yield (%): 0
Retained earnings: 12800400000
Inventory turnover: 4.17877094972067
Receivables turnover: 7.290674450760486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.3889335420280045
FCF margin (%): -13.13876303866821
Revenue growth (%): -3.3478449044018435
Rule of 40 score: -16.486607943070055
Financial ratios for AEP.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 94.56666666666666
Shares outstanding: 544105032
Market cap (USD): 51454199192.799995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEP.DE — annual report dated 2024-12-31
Total revenue: 19721000000
Gross profit: 12460000000
Operating income: 4447000000
Net income: 2976000000
Capital expenditures: 140000000
Operating cash flow: 6804000000
Depreciation & amortization: 3393000000
Net tangible assets: 26891000000
Owner earnings: 6229000000
Return on net tangible assets (%): 23.163883827302815
Capex to operating income (%): 3.1481897908702496
Buffett classification: The Great
Stock price: 88.65625
P/E ratio: 16.209110128780242
Shares outstanding: 544105032
Book value: 26986000000
P/B ratio: 1.7875310065682206
Market cap (USD): 48238311743.25
Debt to equity: 1.6958052323426962
Current ratio: 0.44499961565070334
Quick ratio: 0.31316780690291335
Effective tax rate (%): -1.371790362293352
Interest coverage ratio: 2.3870101986044014
COGS to revenue (%): 36.81861974544901
Free cash flow (dilution-adjusted): -967000000
Buyback yield (%): 0
Retained earnings: 13869000000
Inventory turnover: 4.233819241982507
Receivables turnover: 7.3861423220973785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.937325827976329
FCF margin (%): -4.903402464378074
Revenue growth (%): 3.8931619428932676
Rule of 40 score: -1.010240521484806
Financial ratios for AEP.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 931100000
Buffett classification: The Gruesome
Stock price: 88.65625
Shares outstanding: 544105032
Market cap (USD): 48238311743.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEP.DE — quarterly report dated 2025-03-31
Total revenue: 5463000000
Gross profit: 3291000000
Operating income: 1284000000
Net income: 802000000
Capital expenditures: 36000000
Operating cash flow: 1450000000
Depreciation & amortization: 833000000
Net tangible assets: 27268200000
Owner earnings: 1599000000
Return on net tangible assets (%): 5.863973419587651
Capex to operating income (%): 2.803738317757009
Buffett classification: The Great
Stock price: 92.51086956521739
P/E ratio: 15.690657620053129
Shares outstanding: 544105032
Book value: 27364000000
P/B ratio: 1.8394836151560605
Market cap (USD): 50335629645.13043
Debt to equity: 1.7150343517029674
Current ratio: 0.4168498065621424
Quick ratio: 0.3057581991672693
Effective tax rate (%): 14.0607424071991
Interest coverage ratio: 2.5939393939393938
COGS to revenue (%): 39.75837451949478
Free cash flow (dilution-adjusted): -686000000
Buyback yield (%): 0
Retained earnings: 14169400000
Inventory turnover: 1.372772089495639
Receivables turnover: 2.035015831626001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4242565081534249
FCF margin (%): -12.557203002013544
Rule of 40 score: -12.557203002013544
Financial ratios for AEP.DE — quarterly report dated 2025-06-30
Total revenue: 5086900000
Gross profit: 3154800000
Operating income: 1399100000
Net income: 1288300000
Capital expenditures: 1368900000
Operating cash flow: 1221100000
Depreciation & amortization: 853500000
Net tangible assets: 29818600000
Owner earnings: 772900000
Return on net tangible assets (%): 2.59200633161852
Capex to operating income (%): 97.84146951611751
Buffett classification: The Gruesome
Stock price: 100.12941176470588
P/E ratio: 26.06368310404079
Shares outstanding: 544105032
Book value: 30968400000
P/B ratio: 1.7592422208566303
Market cap (USD): 54480916792.376465
Debt to equity: 1.505554048643133
Current ratio: 0.5524542745536689
Quick ratio: 0.41071194498090585
Effective tax rate (%): -24.675452399685287
Interest coverage ratio: 2.8582226762002043
COGS to revenue (%): 37.98187501228646
Free cash flow (dilution-adjusted): -2068000000
Buyback yield (%): 0
Retained earnings: 14896700000
Inventory turnover: 1.1911837237977805
Receivables turnover: 1.7488568776429332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4523247992426445
FCF margin (%): -40.65344315791543
Revenue growth (%): -6.884495698334249
Rule of 40 score: -47.53793885624968
Financial ratios for AEP.DE — quarterly report dated 2025-09-30
Total revenue: 6010400000
Gross profit: 3625100000
Operating income: 1521400000
Net income: 1000300000
Capital expenditures: 1316000000
Operating cash flow: 2459700000
Depreciation & amortization: 879600000
Net tangible assets: 30336800000
Owner earnings: 563900000
Return on net tangible assets (%): 1.8587985548904302
Capex to operating income (%): 86.49927698172736
Buffett classification: The Gruesome
Stock price: 100.12941176470588
P/E ratio: 17.627941756415087
Shares outstanding: 544105032
Book value: 31479300000
P/B ratio: 1.7306902247628273
Market cap (USD): 54480916792.376465
Debt to equity: 1.5213171830377423
Current ratio: 0.6861646795230856
Quick ratio: 0.5275566135872609
Effective tax rate (%): 12.407192056534573
Interest coverage ratio: 2.991937069813176
COGS to revenue (%): 39.686210568348194
Free cash flow (dilution-adjusted): 1794700000
Buyback yield (%): 0
Retained earnings: 15369300000
Inventory turnover: 1.5042567951062622
Receivables turnover: 2.0777101769911503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5175166748291125
FCF margin (%): 29.859909490216957
Revenue growth (%): 18.154475220664846
Rule of 40 score: 48.0143847108818
Financial ratios for AEP.DE — annual report dated 2025-12-31
Total revenue: 21876000000
Gross profit: 13346000000
Operating income: 5385000000
Net income: 3696000000
Capital expenditures: 130000000
Operating cash flow: 6944000000
Depreciation & amortization: 3489000000
Net tangible assets: 31085000000
Owner earnings: 7055000000
Return on net tangible assets (%): 22.695834003538685
Capex to operating income (%): 2.414113277623027
Buffett classification: The Great
Stock price: 114.91764705882355
P/E ratio: 16.917551415126052
Shares outstanding: 544105032
Book value: 32218000000
P/B ratio: 1.9407557896302032
Market cap (USD): 62527270030.30589
Debt to equity: 1.5366565274070396
Current ratio: 0.4545591107105303
Quick ratio: 0.3327324620700015
Effective tax rate (%): 3.4640171858216973
Interest coverage ratio: 2.6579466929911155
COGS to revenue (%): 38.99250319985372
Free cash flow (dilution-adjusted): -1639000000
Buyback yield (%): 0
Retained earnings: 15441000000
Inventory turnover: 5.258939580764488
Receivables turnover: 7.4105691056910565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.323987107745239
FCF margin (%): -7.4922289266776385
Revenue growth (%): 10.927437756706048
Rule of 40 score: 3.43520883002841
Financial ratios for AEP.DE — quarterly report dated 2025-12-31
Total revenue: 5315300000
Gross profit: 3274100000
Operating income: 1180300000
Net income: 605200000
Capital expenditures: 41100000
Operating cash flow: 1813200000
Depreciation & amortization: 922900000
Net tangible assets: 31085000000
Owner earnings: 1487000000
Return on net tangible assets (%): 4.783657712723179
Capex to operating income (%): 3.482165551131068
Buffett classification: The Great
Stock price: 114.91764705882355
P/E ratio: 16.918466916582577
Shares outstanding: 544105032
Book value: 32218000000
P/B ratio: 1.9407557896302032
Market cap (USD): 62527270030.30589
Debt to equity: 1.5366565274070396
Current ratio: 0.4545591107105303
Quick ratio: 0.3327324620700015
Effective tax rate (%): 16.533295227207773
Interest coverage ratio: 2.2140311386231475
COGS to revenue (%): 38.40234793896864
Free cash flow (dilution-adjusted): -679700000
Buyback yield (%): 0
Retained earnings: 15441000000
Inventory turnover: 1.258446362515413
Receivables turnover: 1.8005758807588075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1669270163921461
FCF margin (%): -12.787613116851354
Revenue growth (%): -11.564954079595369
Rule of 40 score: -24.35256719644672
Financial ratios for AGS.BR — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 328409090.90909094
Buffett classification: The Gruesome
Stock price: 36.59090909090909
Shares outstanding: 209227654
Market cap (USD): 7655830066.818182
Buyback yield (%): 0
Retained earnings: 960227272.7272727
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGS.BR — annual report dated 2022-12-31
Total revenue: 5206382978.723405
Net income: 1365957446.8085108
Capital expenditures: 64893617.0212766
Operating cash flow: 1084042553.1914895
Depreciation & amortization: 413829787.2340426
Net tangible assets: 5913829787.234043
Owner earnings: 1714893617.0212767
Return on net tangible assets (%): 28.99802122683936
Buffett classification: The Gruesome
Stock price: 34.446808510638306
P/E ratio: 5.276317318161994
Shares outstanding: 209227654
Book value: 8442553191.489365
P/B ratio: 0.8536783564163306
Market cap (USD): 7207224932.468087
Debt to equity: 0.559853830645161
Effective tax rate (%): 13.767629281396912
COGS to revenue (%): 0
SG&A to revenue (%): 4.209235798937474
Free cash flow (dilution-adjusted): 910638297.8723406
Buyback yield (%): 1.372735985622772
Retained earnings: 1075531914.8936172
Receivables turnover: 9.947154471544716
Capitalized R&D asset: 0
FCF margin (%): 17.49080506742951
Rule of 40 score: 17.49080506742951
Financial ratios for AGS.BR — annual report dated 2023-12-31
Total revenue: 8755555555.555555
Net income: 1307777777.7777777
Capital expenditures: 138888888.8888889
Operating cash flow: 134444444.44444445
Depreciation & amortization: 380000000
Net tangible assets: 6602222222.222222
Owner earnings: 1548888888.8888888
Return on net tangible assets (%): 23.46011443958263
Buffett classification: The Gruesome
Stock price: 36.955555555555556
P/E ratio: 5.912414419745115
Shares outstanding: 209227654
Book value: 9443333333.333328
P/B ratio: 0.8187918310436526
Market cap (USD): 7732124191.155556
Debt to equity: 0.5394752323802804
Effective tax rate (%): 17.577030812324928
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -128888888.88888888
Buyback yield (%): 0.04311018875183342
Capitalized R&D asset: 0
FCF margin (%): -1.4720812182741116
Revenue growth (%): 68.1696408300413
Rule of 40 score: 66.69755961176719
Financial ratios for AGS.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 6381250000
Buffett classification: The Gruesome
Stock price: 44.375
Shares outstanding: 209227654
Book value: 9163541666.666672
P/B ratio: 1.0131974605433665
Market cap (USD): 9284477146.25
Debt to equity: 0.5398431283392062
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGS.BR — annual report dated 2024-12-31
Total revenue: 8996875000
Net income: 1363541666.6666667
Capital expenditures: 250000000
Operating cash flow: 1088541666.6666667
Depreciation & amortization: 322916666.6666667
Net tangible assets: 6381250000
Owner earnings: 1436458333.3333335
Return on net tangible assets (%): 22.51061051256938
Buffett classification: The Gruesome
Stock price: 44.375
P/E ratio: 6.809089427349122
Shares outstanding: 209227654
Book value: 9163541666.666672
P/B ratio: 1.0131974605433665
Market cap (USD): 9284477146.25
Debt to equity: 0.5398431283392062
Effective tax rate (%): 16.888888888888893
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 663541666.6666666
Buyback yield (%): 0.8414582616701758
Capitalized R&D asset: 0
FCF margin (%): 7.37524603450272
Revenue growth (%): 2.756186548223353
Rule of 40 score: 10.131432582726074
Financial ratios for AGS.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 7531764705.882353
Buffett classification: The Gruesome
Stock price: 63.49411764705882
Shares outstanding: 209227654
Book value: 10751764705.882355
P/B ratio: 1.2355855658584087
Market cap (USD): 13284725278.094118
Debt to equity: 0.5743516796148375
Buyback yield (%): 0
Retained earnings: 796470588.2352941
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AJANTPHARM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.112620334959779
Shares outstanding: 124935624
Market cap (USD): 1888104651.823289
Buyback yield (%): 0
Retained earnings: 358393775.55057365
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AJANTPHARM.NS — annual report dated 2023-03-31
Total revenue: 451585870.8891596
Gross profit: 315565164.43361753
Operating income: 82796589.52496955
Net income: 71617539.58587089
Capital expenditures: 88915.95615103532
Operating cash flow: 96481120.58465287
Depreciation & amortization: 15931790.499390988
Net tangible assets: 411722289.89037764
Owner earnings: 87460414.12911084
Return on net tangible assets (%): 21.242574491752062
Capex to operating income (%): 0.10739084382723313
Buffett classification: The Great
Stock price: 14.05590742996346
P/E ratio: 24.520300136018236
Shares outstanding: 124935624
Book value: 412666260.6577345
P/B ratio: 4.255457092251158
Market cap (USD): 1756083565.6487212
Debt to equity: 0.010516559966233666
Current ratio: 2.4875359876413174
Quick ratio: 1.7716189172108703
Effective tax rate (%): 21.1029855753103
Interest coverage ratio: 116.3972602739726
COGS to revenue (%): 30.120673657862934
SG&A to revenue (%): 9.242836181598479
Free cash flow (dilution-adjusted): 75200974.42143728
Buyback yield (%): 0.009987899331208534
Retained earnings: 382615103.53227776
Inventory turnover: 1.3691624878927946
Receivables turnover: 3.5079193868861767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.203670326069144
FCF margin (%): 16.6526411185914
Rule of 40 score: 16.6526411185914
Financial ratios for AJANTPHARM.NS — annual report dated 2024-03-31
Total revenue: 499051445.01738816
Gross profit: 365303993.2845665
Operating income: 125391533.75704521
Net income: 97873845.78486629
Capital expenditures: 1604508.933924931
Operating cash flow: 94144381.82036215
Depreciation & amortization: 16236958.867969781
Net tangible assets: 426035495.8628133
Owner earnings: 112506295.71891114
Return on net tangible assets (%): 26.407728184963027
Capex to operating income (%): 1.2795990972036266
Buffett classification: The Great
Stock price: 26.226607485604607
P/E ratio: 33.47817330913272
Shares outstanding: 124935624
Book value: 427793500.4197146
P/B ratio: 7.659390730346123
Market cap (USD): 3276637571.6170826
Debt to equity: 0.00988963858528832
Current ratio: 3.050455180117286
Quick ratio: 2.1251717397375036
Effective tax rate (%): 26.730584507105476
Interest coverage ratio: 145.02635228848823
COGS to revenue (%): 26.800333526368526
SG&A to revenue (%): 9.19504324068445
Free cash flow (dilution-adjusted): 75209257.70476076
Buyback yield (%): 1.4209914181844339
Retained earnings: 397451732.82168126
Inventory turnover: 1.3464194311651938
Receivables turnover: 3.33770973019794
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.934835458999665
FCF margin (%): 15.07044182632119
Revenue growth (%): 10.510863423333019
Rule of 40 score: 25.581305249654207
Financial ratios for AJANTPHARM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 437605112.2790253
Buffett classification: The Gruesome
Stock price: 37.47730530339226
Shares outstanding: 124935624
Book value: 439196129.95699954
P/B ratio: 10.660955788422468
Market cap (USD): 4682250523.917821
Debt to equity: 0.008917717129686288
Current ratio: 3.0745316333153654
Quick ratio: 2.144222835832389
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AJANTPHARM.NS — quarterly report dated 2024-12-31
Total revenue: 133597155.84566964
Gross profit: 103545867.81676185
Operating income: 68443874.57745658
Net income: 27145354.93647278
Capital expenditures: 0
Depreciation & amortization: 4192796.363212495
Owner earnings: 31338151.299685277
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 33.7996269961534
P/E ratio: 38.89042434344727
Shares outstanding: 124935624
Market cap (USD): 4222777489.7316704
Effective tax rate (%): 24.239565372978955
Interest coverage ratio: 74.23261694058155
COGS to revenue (%): 22.493957927983736
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AJANTPHARM.NS — quarterly report dated 2025-03-31
Total revenue: 136826046.2941314
Gross profit: 103693009.11854103
Operating income: 66335047.93079261
Net income: 26333878.887070373
Capital expenditures: 0
Depreciation & amortization: 4650455.927051672
Net tangible assets: 437663081.5992518
Owner earnings: 30984334.814122044
Return on net tangible assets (%): 7.079494733917949
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.270743377290234
P/E ratio: 35.90331516488527
Shares outstanding: 124935624
Book value: 443101472.99508995
P/B ratio: 8.535052224544355
Market cap (USD): 3781894212.7856226
Debt to equity: 0.0125109160512784
Current ratio: 2.85416122879229
Quick ratio: 1.946772412408393
Effective tax rate (%): 16.387661927916554
Interest coverage ratio: 93.4810543657331
COGS to revenue (%): 24.215445869396195
Buyback yield (%): 0
Retained earnings: 429258826.28010285
Inventory turnover: 0.3135697294905128
Receivables turnover: 0.9895750545343863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.119213207758442
Revenue growth (%): 2.4168856200739364
Rule of 40 score: 2.4168856200739364
Financial ratios for AJANTPHARM.NS — annual report dated 2025-03-31
Total revenue: 536299976.61912555
Gross profit: 404531213.4673836
Operating income: 131921907.87935469
Net income: 107597615.15080664
Capital expenditures: 133270.9843348141
Operating cash flow: 135285246.66822538
Depreciation & amortization: 16847089.081131633
Net tangible assets: 437663081.5992518
Owner earnings: 124311433.24760346
Return on net tangible assets (%): 28.403454272030597
Capex to operating income (%): 0.10102263261435938
Buffett classification: The Great
Stock price: 30.270743377290234
P/E ratio: 35.14849476435883
Shares outstanding: 124935624
Book value: 443101472.99508995
P/B ratio: 8.535052224544355
Market cap (USD): 3781894212.7856226
Debt to equity: 0.0125109160512784
Current ratio: 2.85416122879229
Quick ratio: 1.946772412408393
Effective tax rate (%): 22.601668404588114
Interest coverage ratio: 54.43608297153884
COGS to revenue (%): 24.56997368943065
SG&A to revenue (%): 10.008043579196556
Free cash flow (dilution-adjusted): 97665419.68669628
Buyback yield (%): 1.0860478856905604
Retained earnings: 429258826.28010285
Inventory turnover: 1.2470542678541794
Receivables turnover: 3.8787138339787277
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.079176878957913
FCF margin (%): 18.21096847745291
Revenue growth (%): 7.463866095095577
Rule of 40 score: 25.674834572548484
Financial ratios for AJANTPHARM.NS — quarterly report dated 2025-06-30
Total revenue: 152428036.508308
Gross profit: 120146267.25953664
Operating income: 79871284.81160778
Net income: 29878305.64006553
Capital expenditures: 0
Depreciation & amortization: 4831500.117013808
Owner earnings: 34709805.75707933
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.786449801076532
P/E ratio: 44.64369649810519
Shares outstanding: 124935624
Market cap (USD): 3721388692.6421723
Effective tax rate (%): 22.888291607525744
Interest coverage ratio: 129.76806083650192
COGS to revenue (%): 21.17836717460561
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.402792550650336
Rule of 40 score: 11.402792550650336
Financial ratios for AJANTPHARM.NS — quarterly report dated 2025-12-31
Total revenue: 153151386.87757602
Gross profit: 121263228.24997215
Operating income: 79597861.20084661
Net income: 30496825.220006686
Capital expenditures: 0
Depreciation & amortization: 4846830.789796146
Owner earnings: 35343656.00980283
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.844380082432885
P/E ratio: 33.846413206910505
Shares outstanding: 124935624
Market cap (USD): 3853561872.491924
Effective tax rate (%): 23.655883993307306
Interest coverage ratio: 140.1078431372549
COGS to revenue (%): 20.821331936807194
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.47455204819134716
Rule of 40 score: 0.47455204819134716
Financial ratios for AKRBP.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.800456100342075
Shares outstanding: 631738272
Market cap (USD): 13140444193.64196
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AKRBP.OL — annual report dated 2022-12-31
Total revenue: 1305283400.8097165
Gross profit: 1030121457.4898784
Operating income: 988147773.2793522
Net income: 162246963.56275302
Capital expenditures: 159919028.34008095
Operating cash flow: 579908906.882591
Depreciation & amortization: 180728744.93927124
Net tangible assets: -389868421.05263156
Owner earnings: 183056680.16194335
Return on net tangible assets (%): -46.95345154339418
Capex to operating income (%): 16.183715904085876
Buffett classification: The Great
Stock price: 22.00404858299595
P/E ratio: 85.67679371977542
Shares outstanding: 631738272
Book value: 1257844129.5546556
P/B ratio: 11.051289505757396
Market cap (USD): 13900799628.82591
Debt to equity: 0.43561456447394903
Current ratio: 0.7611472103965943
Quick ratio: 0.7276175538555104
Effective tax rate (%): 81.73614829837413
Interest coverage ratio: 128.62845849802372
COGS to revenue (%): 21.08062840216498
Free cash flow (dilution-adjusted): 394504048.5829959
Buyback yield (%): 0
Inventory turnover: 12.976610978520286
Receivables turnover: 13.56209906404459
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.17782688672015
FCF margin (%): 30.223631767497398
Rule of 40 score: 30.223631767497398
Financial ratios for AKRBP.OL — annual report dated 2023-12-31
Total revenue: 1333988212.1807466
Gross profit: 993438113.9489195
Operating income: 945265225.9332024
Net income: 131208251.47347741
Capital expenditures: 311552062.86836934
Operating cash flow: 531149312.37721026
Depreciation & amortization: 236424361.49312377
Net tangible assets: -285255402.75049114
Owner earnings: 56080550.09823185
Return on net tangible assets (%): -19.659767898343617
Capex to operating income (%): 32.95922184811074
Buffett classification: The Good
Stock price: 22.606090373280942
P/E ratio: 108.84324963342067
Shares outstanding: 631738272
Book value: 1214361493.1237721
P/B ratio: 11.760198713445826
Market cap (USD): 14281132469.092337
Debt to equity: 0.5259905194868227
Current ratio: 0.9460325056599606
Quick ratio: 0.9087964070754109
Effective tax rate (%): 84.759242355089
Interest coverage ratio: 85.53599999999999
COGS to revenue (%): 25.528718703976438
Free cash flow (dilution-adjusted): 196159135.5599214
Buyback yield (%): 0
Inventory turnover: 17.136925358378647
Receivables turnover: 15.50759392486011
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.627698312587764
FCF margin (%): 14.704712812960235
Revenue growth (%): 2.199124830149791
Rule of 40 score: 16.903837643110027
Financial ratios for AKRBP.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.072519083969464
Shares outstanding: 631738272
Market cap (USD): 11417101976.793892
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AKRBP.OL — annual report dated 2024-12-31
Total revenue: 1080556045.8958516
Gross profit: 788040600.1765225
Operating income: 738252427.184466
Net income: 161315092.674316
Capital expenditures: 421332744.92497796
Operating cash flow: 566866725.5075022
Depreciation & amortization: 211632833.18623126
Net tangible assets: -176796116.50485438
Owner earnings: -48384819.06443071
Capex to operating income (%): 57.07163693749702
Buffett classification: The Good
Stock price: 16.84567901234568
P/E ratio: 65.97064151592754
Shares outstanding: 631738272
Book value: 1120132391.8799648
P/B ratio: 9.500716368057988
Market cap (USD): 10642060149.925926
Debt to equity: 0.6440182490091481
Current ratio: 1.3656402303943285
Quick ratio: 1.2978732831191846
Effective tax rate (%): 77.29198504106253
Interest coverage ratio: 159.0190114068441
COGS to revenue (%): 27.070825879912114
Free cash flow (dilution-adjusted): 115639894.08649603
Buyback yield (%): 0
Retained earnings: -96443071.49161518
Inventory turnover: 10.83425956194835
Receivables turnover: 13.381462454913104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.199161865128758
FCF margin (%): 10.70188765550083
Revenue growth (%): -18.998081390134246
Rule of 40 score: -8.296193734633416
Financial ratios for AKRBP.OL — quarterly report dated 2024-12-31
Total revenue: 267043248.0141218
Gross profit: 193556928.50838482
Operating income: 178949691.0856134
Net income: 49585172.109443955
Capital expenditures: 119638128.86142983
Operating cash flow: 93777581.6416593
Depreciation & amortization: 53256840.24713151
Net tangible assets: -176796116.50485438
Owner earnings: -16796116.504854366
Capex to operating income (%): 66.8557336621455
Buffett classification: The Good
Stock price: 16.84567901234568
P/E ratio: 53.655456345078655
Shares outstanding: 631738272
Book value: 1120132391.8799648
P/B ratio: 9.500716368057988
Market cap (USD): 10642060149.925926
Debt to equity: 0.6440182490091481
Current ratio: 1.3656402303943285
Quick ratio: 1.2978732831191846
Effective tax rate (%): 72.62183235867447
Interest coverage ratio: 266.77631578947364
COGS to revenue (%): 27.51850872554204
Free cash flow (dilution-adjusted): -25860547.21977052
Buyback yield (%): 0
Retained earnings: -96443071.49161518
Inventory turnover: 2.7218045112781954
Receivables turnover: 3.3070280905016944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.380995729705484
FCF margin (%): -9.684029613960869
Rule of 40 score: -9.684029613960869
Financial ratios for AKRBP.OL — quarterly report dated 2025-03-31
Total revenue: 300572519.0839695
Gross profit: 208062977.09923664
Operating income: 192051526.71755725
Net income: 30162213.740458015
Capital expenditures: 195314885.4961832
Operating cash flow: 151354961.83206105
Depreciation & amortization: 64589694.656488545
Net tangible assets: -176145038.16793892
Owner earnings: -100562977.09923662
Capex to operating income (%): 101.69921001639588
Buffett classification: The Gruesome
Stock price: 21.120229007633586
P/E ratio: 110.58917203770957
Shares outstanding: 631738272
Book value: 1203187022.900763
P/B ratio: 11.089262702783639
Market cap (USD): 13342456977.526716
Debt to equity: 0.6526321633067396
Current ratio: 1.2636201164555987
Quick ratio: 1.1953994273305533
Effective tax rate (%): 83.66154959425234
Interest coverage ratio: 529.6578947368422
COGS to revenue (%): 30.777777777777775
Free cash flow (dilution-adjusted): -43959923.664122134
Buyback yield (%): 0
Retained earnings: -112061068.70229007
Inventory turnover: 2.7309859154929574
Receivables turnover: 3.5070140280561124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.283550823364494
FCF margin (%): -14.625396825396825
Revenue growth (%): 12.555745677596978
Rule of 40 score: -2.0696511477998474
Financial ratios for AKRBP.OL — quarterly report dated 2025-06-30
Total revenue: 251578947.36842105
Gross profit: 164538232.3733863
Operating income: 152353525.32274082
Net income: -32174776.56405164
Capital expenditures: 185342601.7874876
Operating cash flow: 123147964.25024825
Depreciation & amortization: 58728897.715988085
Net tangible assets: -182820258.19265142
Owner earnings: -158788480.63555115
Capex to operating income (%): 121.65297875114065
Buffett classification: The Gruesome
Stock price: 23.365441906653423
P/E ratio: 310.2803086946921
Shares outstanding: 631738272
Book value: 1176842105.2631578
P/B ratio: 12.542756439977046
Market cap (USD): 14760843894.625618
Debt to equity: 0.7348027137408445
Current ratio: 1.2193391154755933
Quick ratio: 1.1176020834826657
Effective tax rate (%): 138.01478352692715
Interest coverage ratio: 143.38317757009347
COGS to revenue (%): 34.59777374279624
Free cash flow (dilution-adjusted): -62194637.53723932
Buyback yield (%): 0
Retained earnings: -191966236.34558094
Inventory turnover: 2.058478158759981
Receivables turnover: 3.925925925925926
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.965160756745581
FCF margin (%): -24.721717849530275
Revenue growth (%): -16.30008354218881
Rule of 40 score: -41.02180139171908
Financial ratios for AKRBP.OL — annual report dated 2025-12-31
Total revenue: 1064577114.4278606
Gross profit: 691552238.8059701
Operating income: 631562189.0547264
Net income: 13164179.10447761
Capital expenditures: 682149253.7313433
Operating cash flow: 692358208.9552238
Depreciation & amortization: 256129353.23383084
Net tangible assets: -129313432.83582088
Owner earnings: -412855721.3930348
Capex to operating income (%): 108.00983110662969
Buffett classification: The Gruesome
Stock price: 24.54980079681275
P/E ratio: 1178.1250171571676
Shares outstanding: 631738272
Book value: 1117034825.870647
P/B ratio: 13.884122834965813
Market cap (USD): 15509048733.32271
Debt to equity: 0.8674261994263417
Current ratio: 1.3088762815783448
Quick ratio: 1.1683669575393696
Effective tax rate (%): 97.12834537995701
Interest coverage ratio: 210.17218543046357
COGS to revenue (%): 35.03972333862978
Free cash flow (dilution-adjusted): -21611940.29850746
Buyback yield (%): 0
Retained earnings: -254487562.1890547
Inventory turnover: 6.7877964874162595
Receivables turnover: 13.692091118505248
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.528204074343183
FCF margin (%): -2.0300962706795027
Revenue growth (%): -1.4787693362766219
Rule of 40 score: -3.5088656069561246